A fascinating novel concept of cancer research using lectibodies, a bispecific construct composed of a lectin linked to an antibody fragment. This approach aims to redirect the immune system into fighting cancer by targeting altered glycans at the surface of malignant cells.
The University of Freiburg, acib GmbH – Francesca Rosato, Rajeev P., Jana Tomisch, Ana Valeria Meléndez Mayorga, Dajana Kolanovic, Olga Makshakova, Birgit Wiltschi, Winfried Römer
